Pharmaceutical News and Articles

Meningitis Substantial Contributor to Mortality in Children Younger Than 5 Years

Meningitis is a substantial contributor to mortality in children younger than 5 years of age in low- and middle-income countries, according to a study published

Integrative CBT for Prolonged Grief Beats Present-Centered Therapy

For patients with prolonged grief disorder (PGD), integrative cognitive behavioral therapy for prolonged grief (PG-CBT) is superior to present-centered therapy

Ultraprocessed Foods Might Help Trigger Psoriasis

Ultraprocessed foods have been linked to a myriad of health issues, and a new study suggests that the autoimmune skin disease psoriasis might be added to that l

Integrated Psychological, Yoga Intervention Aids Depression, Anxiety With Cancer

An integrated psychological and yoga intervention may reduce depressive symptoms and state anxiety among women with cancer, according to a proof-of-concept stud

Healthy Prenatal Diet Tied to Healthier Infant Growth Patterns

Adhering to a healthy prenatal diet may reduce patterns of infant growth outside reference ranges, according to a study published online Nov. 21 in JAMA Network

Sodium Oxybate Beneficial for Alcohol-Responsive Laryngeal Dystonia

Sodium oxybate improves symptoms of alcohol-responsive (EtOH-positive) isolated laryngeal dystonia (LD), according to a study published online Nov. 20 in the An

U.S. Abortion Numbers Dipped Slightly in 2022

The rate and number of abortions among U.S. women took a slight dip in 2022 compared to 2021, according to the latest data from the U.S. Centers for Disease Con

FDA Approves Rapiblyk (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting

Air Pollution Exposure Throughout Pregnancy Ups Risk for Spontaneous Preterm Birth

Exposures to fine particulate matter (PM2.5) and specific PM2.5 constituents during pregnancy is associated with increased odds of spontaneous preterm birth (sP

FDA Approves Kebilidi for Aromatic L-Amino Acid Decarboxylase Deficiency

The U.S. Food and Drug Administration has approved Kebilidi (eladocagene exuparvovec-tneq) for the treatment of adult and pediatric patients with aromatic L-ami